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Abstract
Purpose Adolescents and young adults (AYA) with Inflammatory Bowel Disease (IBD) report higher depressive symptoms 
and anxiety compared to healthy controls, with disease severity and abdominal pain being important factors. In the current 
study, building on what young people had told us in our previous work, we examined whether embarrassment of the condi-
tion, social self-efficacy, and friendship quality mediated the relationship between abdominal pain and disease severity, and 
mental health/well-being. We also included loneliness as a component of well-being.
Methods Data on depression, anxiety, loneliness, friendship quality, social self-efficacy, and disease embarrassment were 
collected from 130 AYA with IBD ages 14–25 years; data on disease severity and abdominal pain were taken from their 
medical records. Structural Equation Modeling (SEM) was used to test the relationships between the variables.
Results Using SEM, we established that higher IBD disease activity negatively impacted how AYA felt about their friend-
ships and how embarrassed they were about their condition; embarrassment then influenced reports of mental health, includ-
ing loneliness. Abdominal pain, disease onset, and social self-efficacy directly predicted internalising problems.
Conclusion In this sample of 14–25-year-old patients with IBD, specifics about the disease (severity and pain) predicted 
poorer mental health, suggesting discussion of mental health should be part of the clinical dialogue between patient and 
consultant. In addition, embarrassment about their condition increased depression, anxiety, and loneliness, mediating the 
relationship between disease severity and well-being. Thus, it is important to consider how perceived stigma affects those 
with chronic illness, and those issues should be explored in clinic.
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What is IBD
Inflammatory Bowel Disease (IBD) is a ‘chronic, heteroge-
neous, relapsing and remitting condition primarily as a con-
sequence of inflammation within the bowel lumen’ [1]. IBD 
includes Crohn’s disease (CD) and ulcerative colitis (UC), 
and is a lifelong disease marked by episodes of remission 
and relapse [2]. IBD is characterised by uncertainty, unpre-
dictability, and the intrusiveness of symptoms [3, 4]; symp-
toms most commonly include diarrhoea, abdominal pain, 
weight loss, blood in the stools, and fatigue [5]. The inci-
dence of IBD in all age groups is increasing worldwide [2, 
6], although the reason is unknown [7]. Worldwide, Europe 
has the highest reported prevalence values for IBD (UC, 
505 per 100,000 persons; CD, 322 per 100,000 persons) and 
North America (UC, 249 per 100,000 persons; CD, 319 per 
 * Pamela Qualter 
 pamela.qualter@manchester.ac.uk
 * Bernie Carter 
 bernie.carter@edgehill.ac.uk
1 Institute of Education, University of Manchester, Manchester 
Oxford Road, Manchester M13 9PL, UK
2 Children, Young People and Families, Faculty of Health, 
Social Care & Medicine, Edge Hill University, St Helens 
Road, Ormskirk L39 4QP, UK
3 Liverpool School of Tropical Medicine, Liverpool, UK
4 Institute of Translational Medicine, University of Liverpool, 
Liverpool, UK
5 St Marks & Northwick Park, London North West University 
Healthcare NHS Trust, London, UK
 Quality of Life Research
1 3
100,000 persons) [6]. The incidence is higher in the north 
compared to the south of Europe [8] and in western Europe 
compared to eastern Europe [9]. The incidence of paediatric-
onset IBD is also rising [10].
IBD and mental health
Individuals with IBD experience potential challenges to their 
psychological well-being: the course of the disease is unpre-
dictable, the treatment and management regimes frustrating. 
Patients talk about the symptoms of the disease often being 
embarrassing and socially limiting [3, 11], which makes 
telling others about their condition difficult [12, 13]. While 
there are few studies with adolescents and young adults 
(AYA) with IBD, those studies show high rates of anxiety 
and depression among that population [14]. Only certain 
studies utilise a control group and those show that depres-
sion and anxiety are considerably higher among AYA with 
IBD than control groups of peers without chronic medical 
conditions [15]; they are comparable to other groups of AYA 
with chronic conditions, such as cystic fibrosis (CF), diabe-
tes, and cancer [15], although rates of lifetime depression, 
but not anxiety, have been found to be higher among those 
with IBD compared to those with CF [16].
Most of the research on mental health among IBD 
patients is focused on depressive symptoms, with some stud-
ies also considering anxiety among AYA. However, missing 
from the discussion is whether AYA with IBD also experi-
ence loneliness. Loneliness is an important issue raised by 
adolescents with chronic diseases [17], and meta-analytic 
findings show that AYA with medical conditions are vul-
nerable to loneliness [18, 19]: AYA talk about feelings of 
disconnection from peers, that such disconnection impacts 
their quality of life, and is part of their poor mental health. 
To date, however, there has been no published work on 
loneliness among AYA with IBD. Loneliness in the gen-
eral population of the AYA in the UK impacts employment 
prospects, with lonelier young people more likely to be out 
of work [20]; they also have difficulties coping with stress 
[20]. The current study is designed to fill the gap in our 
knowledge about loneliness among AYA with IBD. Given 
the associations between loneliness, depressive symptoms, 
and anxiety among AYA [21], an exploration of how IBD is 
associated with all three internalising problems is needed.
Risk factors for poor mental health 
among AYA with IBD
Given that mental health problems impact quality of life and 
adherence to medication for those with IBD [22], it is impor-
tant to understand risk factors for mental health problems 
for those with IBD. Findings from empirical studies sug-
gest that, for IBD among AYA, disease severity (activity 
and pain) has an impact on mental health and well-being, 
although that effect is found in some studies, but not others 
[23]. In studies that found an effect, paediatric patients with 
IBD who reported greater disease activity and more pain 
also reported poorer mental health and well-being compared 
to peers with IBD in remission [24]: functional impairment 
and the aggressive treatment regimens for IBD contribute 
to negative affect.
Disease severity accounts for a small amount of variation 
in reports of well-being and mental health [25], suggesting 
that other factors are important. Given that those with IBD 
also report social problems more frequently than healthy 
peers [23], it is possible that problems with social relation-
ships are key predictors of mental health problems among 
AYA with IBD. There is a social taboo related to bowel 
symptoms in most cultures, so IBD is susceptible to condi-
tion-related stigma [26], which means those with IBD report 
high levels of shame/embarrassment associated with hav-
ing the condition [11, 27]. Fears of abdominal pain, bowel 
noises, faecal incontinence, and/or a bowel urgency in public 
mean many people with IBD withdraw from social interac-
tions because they feel ashamed. IBD nondisclosure due to 
embarrassment is also a reported problem in the literature 
[13, 26], but, because concealment of any condition is asso-
ciated with reduced engagement with others [28], feelings 
of disconnection and negative affect are likely to be high 
among those with IBD because of social problems as much 
as they are to do with disease severity. Indeed, recent work 
by Roberts, Gamwell et al. [29] showed that difficulty com-
municating about their illness to others was associated with 
thwarted belonging that was also linked to higher depres-
sion. Thus, where stigmatised beliefs are internalised to 
become part of one’s identity, there are potential impacts on 
mental health [28]: feeling ashamed of one’s self because of 
their IBD is likely to increase feelings of disconnection and 
depression. Gambin and Sharp [30] point out that AYA are 
particularly vulnerable to self-consciousness, which impacts 
their mental health; given too, that heightened shame and 
low social self-efficacy during this time increase feelings of 
loneliness [19], it seems that AYA with IBD may be particu-
larly at risk of internalising problems. Thus, in the current 
study we explore how feelings of embarrassment of IBD 
impact mental health, including loneliness, controlling for 
social self-efficacy and friendship quality.
The current study
The current study explores [1] whether, among adolescents 
and young adults (AYA) with IBD, disease symptoms 
are associated with poor mental health and well-being, 
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including loneliness, and [2] examines how embarrass-
ment of the condition, social self-efficacy, and friendship 
quality influence loneliness and whether they mediate the 
relationship between abdominal pain and disease severity, 
and mental health.
Method
Participants and procedure
The study was a cross-sectional questionnaire design. 
AYA, ages 14 to 25  years, with Inflammatory Bowel 
Disease (IBD) were invited to participate. They were 
patients attending the outpatient clinics or day units in 
three hospitals (two in Liverpool and one in London, 
United Kingdom). Eligibility criteria consisted of being 
between the ages of 14 and 25 years, with a diagnosis of 
IBD and beyond the first 3 months after diagnosis, able to 
provide assent/consent to participate, and able to complete 
the questionnaires and converse in English. Patients were 
excluded if they were judged by a clinician as too unwell 
and/or distressed to participate. Those with new-onset IBD 
were not included in the study because we saw that as a 
period of adjustment and did not want to add extra bur-
den. AYA for the study were identified and screened by a 
research nurse; if they expressed interest in the study, a 
trained researcher approached the young person (and par-
ent, as appropriate) and explained the study and provided 
them with an appropriate participant information sheet 
(PIS). They were then given a minimum of 20 min to think 
about the information before the researcher returned to ask 
if they were still interested and wished to participate in the 
study. Informed consent/assent was then sought by that 
researcher and documented using the appropriate consent 
and assent forms. All young people were able to provide 
consent or, if deemed more appropriate, assent with their 
parent/guardian providing consent. All young people and 
their parents provided written consent/assent.
130 young people with IBD consented to take part in the 
study. This was a response rate of 78%. To ensure patient 
confidentiality, and for the purpose of database manage-
ment, clinical data and completed questionnaires were 
numerically coded, providing anonymity. The research 
nurses collated clinical data including demographics, age 
of diagnosis, IBD classification, disease activity scores, 
and symptoms for each participant. Ethics approval for the 
study was obtained from the North West-Liverpool East 
Research Ethics Committee (18/NW/0178) and research 
ethics committees at Edge Hill University and the Univer-
sity of Manchester. Research approval was granted by all 
participating sites.
Measures
AYA in the ‘Being Me with IBD’ study completed question-
naires that measured mental health as follows: loneliness, 
depressive symptoms, and anxiety. They also completed 
questionnaires that examined friendship quality, social 
self-efficacy, and how their embarrassment of the condition 
impacted their relationships. Questionnaires were completed 
on iPads or on paper, depending on the participant’s prefer-
ence. The questionnaires took approximately 10–15 min to 
complete.
Demographic and clinical variables
Current age, gender, and age of onset of IBD symptoms were 
recorded. Research nurses also provided data on IBD clas-
sification and disease activity scores using Harvey-Bradshaw 
Index (HBI)—Simple Index of Crohn’s Disease Activity (for 
those age 17 and above with Crohn’s Disease), Simple Clini-
cal Colitis Activity Index (SCCAI) (for those age 17 and 
above with ulcerative colitis or indeterminate colitis), Pae-
diatric Ulcerative Colitis Activity Index (PUCAI) (for those 
age 16 and below with Ulcerative Colitis or IBD-unclas-
sified) and Weighted Paediatric Crohn’s Disease Activity 
Index (wPCDAI) (for those age 16 and below with Crohn’s 
Disease). Using those scales enabled IBD activity to be com-
pared across the different age groups using the classification 
Remission, Mild disease, Moderate disease, and severe dis-
ease. Research nurses also provided data on abdominal pain. 
The HBI scores abdominal pain on a 0–3 scale, PUCAI on a 
0, 5, 10 scale, and the wPCDAI on a scale of 0, 10, 20. For 
analysis, all pain scores were reclassified as 0, 1, or 2 (no 
pain, mild pain, moderate/severe pain). Pain scores for all 
patients with ulcerative colitis/IBD-unclassified colitis were 
not collected through the SCCAI, so not all patients were 
included in those sections of our analyses. Patient charac-
teristics are provided in Table 1.
Mental health variables
Validated measures of anxiety, depressive symptoms, and 
loneliness were administered. Anxiety was measured using 
the GAD-7 [31, 32]. GAD-7 is a seven-item measure of 
anxiety symptoms. Each item is rated using a four-point 
response scale from 0 (not at all) to 3 (nearly every day), 
giving a severity score between 0 and 21. A score above 7 is 
recommended to identify a likely anxiety disorder. Depres-
sion was measured using the Patient Health Questionnaire 8 
(PHQ-8), a measure of depressive symptoms. PHQ-8 is the 
same as the PHQ-9, but without the item ‘How often have 
you been bothered by thoughts that you would be better off 
dead or of hurting yourself in some way? and includes the 
same response options as for the GAD-7. The presence of 
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Item 9, asking about suicidal ideation, has been highlighted 
as a potential problem [33]. However, Wu et al. [34] have 
shown its removal has minimal influence on depression 
score, but reduces the number of false positives from peo-
ple who endorse this item but would not be considered to 
be at risk for suicide based on measures intended to assess 
suicide risk. Total severity scores for the PHQ-8 are between 
0 and 27. A score greater than 9 indicates clinically sig-
nificant depression. The PHQ-9 is well validated against 
standard criteria, demonstrates sensitivity to change, and is 
used in a variety of clinical settings [31, 35, 36]. PHQ-9 
and GAD-7 form part of the UK Department of Health’s 
National Minimum Data Set [37]; the National Institute for 
Health and Care Excellence supports their use for assessing 
clinical progress in mental health services [38]. Loneliness 
was measured using the three-item University of Califor-
nia, Los Angeles (UCLA) Loneliness Scale [39]. It asks 
how often the respondent feels left out, isolated from oth-
ers, or lacks companionship. Each question was scored on a 
three-point scale of ‘never or hardly ever’ [1] ‘some of the 
time’ [2] and ‘often’ [3]. A score of six or more was classed 
as lonely. This version of the UCLA is used frequently in 
research with AYA and is the recommended loneliness item 
for research and evaluation studies by the Office of National 
Statistics [40].
Social functioning
AYA in the study also completed validated measures that 
allowed us to explore their perceived closeness to friends, 
their confidence at social interaction, and embarrassment 
at having IBD. The Friendship Respondent Affection 
Scale (FRAS) [41] provides information on closeness the 
AYA feels towards their friends. Participants rated agree-
ment with each of the items on a 9-point scale (− 4 to + 4), 
which has four points labelled − 3 = very much disagree, 
− 1 = somewhat disagree, 1 = somewhat agree, and 3 = very 
much agree. Sample items include “I am satisfied with my 
friendship with [friend’s name],” “I think my friendship with 
[friend’s name] is strong,” and “I hope [friend’s name] and 
I will stay friends”. The Scale of Perceived Social Self-
Efficacy (PSSE) [42] is a measure of an individual’s degree 
of perceived social self-efficacy, defined as an individual’s 
degree of self- confidence involving social behaviour. The 
PSSE has been shown to be reliable and valid [42]. The 
instrument consists of 25 rationally derived items that meas-
ure the level of confidence in a variety of social situations. 
Responses are obtained using a five-point scale ranging from 
1 (no confidence at all) to 5 (complete confidence). Exam-
ples items include “Find someone to go to lunch with” and 
“Put yourself in a new and different social situation”. Item 
Table 1  Demographics of 
current sample
† SCCAI simple clinical colitis activity index (SCCAI) was categorised as remission (SCCAI ≤ 2), mild 
disease (SCCAI 3–5), moderate disease (SCCAI 6–11) and severe disease (SCCAI ≥ 12); 6% of AYA did 
not have data for this variable. This made the disease activity indicators/groups comparable for Adults 
with Crohn’s (measured using HBI), children with colitis (measured using the PUCAI), and children with 
Crohn’s (measured using wPCDAI) because they all use the same scale of remission, mild disease, moder-
ate disease, and severe disease activity
Characteristics Range/response scale Mean (SD) or %
Age (years) 14.00–25.00 18.69 (3.65)
Mean age at onset of IBD 4.00–25.00 14.17 (4.15)
Males % 42%
White British 84%
Ulcerative Colitis 31%
Crohn’s disease 64%
IBD-unclassified 5%
Current abdominal pain: no pain 57%
Current abdominal pain: mild pain 18%
Current abdominal pain: moderate/severe pain 2%
Current disease activity:  remission† 55%
Current disease activity:  mild† 29%
Current disease activity: moderate/severe† 10%
Mean GAD-7 score 0.00–20.00 6.29 (5.31)
Mean PHQ-8 score 0.00–21.00 6.52 (5.42)
Mean UCLA score 2.28–9.00 3.83 (1.26)
Mean friendship function score 0.25–4.04 3.36 (0.76)
Mean social self-efficacy score 1.56–5.00 3.18 (0.77)
IMPACT III embarrassment scale score 2.33–4.67 3.91 (0.47)
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scores are summed and then divided by 25, yielding total 
scores ranging from 1 to 5. Together, the PSSE and FRAS 
enabled us to examine whether AYA with IBD are [1] satis-
fied with their social relationships and [2] confident in their 
ability to make and keep effective relationships. We used the 
IMPACT III (UK) Embarrassment subscale to explore 
whether AYA with IBD in the current sample reported being 
embarrassed by their condition and how they engaged with 
others in social relationships. The subscale has six items and 
AYA in the study used a five-point scale to rate each item 
1 (not at all) to 5 (very much). Example items include “Are 
you embarrassed because of your bowel condition?” and 
“Do you try and hide your IBD?”.
Analysis plan
Summary statistics were undertaken using SPSS version 23 
(SPSS Inc., Chicago, IL, USA). Three multiple regressions 
were also conducted, with loneliness, depressive symptoms, 
and anxiety as the dependent variables respectively. Based 
on previous work it was decided to include clinical vari-
ables that were comparable across IBD groups. Therefore, 
in Step 1, the block of demographic variables was entered 
(age, gender, and disease onset). In Step 2, we entered the 
clinical data linked to current disease activity and pain level. 
Based on the hypotheses that embarrassment of the condi-
tion, social self-efficacy, and friendship quality would be 
important predictors of internalising problems, those were 
entered in Step 3. Given the problems with over-fitting and 
model selection [43], bootstrapping was used to check the 
robustness of the findings. Bootstrapping is a method of re-
sampling many times from the observed data; it allowed us 
to check the statistical methods by applying them to a large 
number of samples. For each multiple regression, the step-
wise procedure was run on 1000 bootstrap replications of 
samples [44]. If a statistically significant coefficient is due 
to a genuine effect, one would expect it to be statistically 
significant in a high proportion of the 1000 bootstrap repli-
cated samples, providing additional information about the 
generalisability of the results and reducing the likelihood of 
making spurious conclusions based on models that may not 
be stable (e.g., due to small samples or Type 1 errors from 
multiple testing). Because it could be argued that conduct-
ing three separate regression analyses may result in Type 1 
errors, in addition to the multiple regressions, the relation-
ships between the variables were explored using Structural 
Equation Modelling (SEM).
We tested two models in SEM. First, we tested the less 
restrictive (Full) model where all pathways were allowed to 
be freely estimated. Then, nonsignificant paths were fixed to 
zero, so the effects of nonsignificant paths could be explored 
through the comparison of path models. Those models were 
compared using the chi-square difference test. In the models, 
we modelled scores of depression, anxiety, and loneliness 
as a latent variable (‘internalising problems’). Clinical data 
(activity of disease and abdominal pain) were defined as 
categorical. In the models, associations between the predic-
tor variables (clinical data) and the latent variable ‘internal-
ising problems’ were modelled, exploring mediator effects 
of embarrassment of the condition, social self-efficacy, and 
friendship closeness (total scores on each measure). The 
models allowed for unconstrained correlations between the 
clinical variables.
All models were tested using MLR in Mplus 7.4. MLR 
was used as the estimator because it uses maximum likeli-
hood (ML) estimation with robust chi-squares and standard 
errors [45] and accounts for the categorical nature of the 
clinical data. MLR produces the same parameter estimates 
as ML, but the chi-square for the model test and the standard 
errors for the parameters are calculated differently. MLR 
also provides the full maximum likelihood for missing data. 
MLR is robust against moderate violations of assumptions, 
including unmodeled heterogeneity [45].
The adequacy of the SEM models was assessed using 
Goodness-of-Fit (GOF) statistics. The degree of model fit 
was used to make interpretations about the relations between 
the variables and the possible mediators. GOF statistics used 
are the chi-square goodness of fit statistic, the comparative 
fit index (CFI), normed fit index (NFI), and the root mean 
square error of approximation (RMSEA) [46]. There are 
rules of thumb about acceptable levels of GOF [47], such 
that RMSEA should be less than 0.10 to be viewed as having 
a reasonable fit to the data; the CFI and NFI should exceed 
0.90; the Chi-square index should be as small as possible. 
Standardised regression coefficients (B) are reported. The 
alpha level is set to 0.05 throughout for the SEM analyses.
Results
Table 1 summarises the means of the study variables. Using 
standard cut-off points for GAD-7, PHQ-8, and UCLA, the 
majority of the young people in the current sample were 
not anxious or experienced only mild anxiety (76%), not 
depressed or suffered mild depression consistent with eve-
ryday stress exposure (90%), and not lonely (89%). 10% of 
the AYA in the study reported severe anxiety, 10% mod-
erate/severe depression, and 11% were very often lonely 
(see Table 2 for details). It was the case that the same AYA 
tended to report all three mental health problems: those who 
reported higher levels of depressive symptoms were also 
more likely than chance to report elevated levels of anxi-
ety and loneliness, and those with higher anxiety were also 
more likely than chance to be lonely, suggesting high levels 
of co-morbidity.
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Associations between clinical data, feelings 
about social situations, and internal/mental health 
problems
To examine whether IBD symptoms and feelings about 
social relationships were related to depressive symptoms, 
anxiety, and loneliness, a series of multiple regressions were 
conducted. Table 3 summarises the results from each regres-
sion, where bootstrapping methods (1000 bootstrap repli-
cations) were used. The models were significant for anxi-
ety (F = 9.88, p < 0.001), depressive symptoms (F = 9.44, 
p < 0.001), and loneliness (F = 2.52, p < 0.001). Results 
suggested that current high pain levels, embarrassment of 
the condition, and lower social self-efficacy were associated 
with higher self-reported anxiety and depressive symptoms, 
with age also associated with higher depressive symptoms. 
IBD symptoms were not associated with reports of loneli-
ness, but embarrassment of the condition and lower social 
self-efficacy was. The bootstrapping results confirmed the 
robustness of the findings.
SEM
The full model where all paths were freely estimated was 
compared against a constrained model in which the non-
significant paths were held to zero. The full model fit the 
data very well (χ2 (df = 12) = 12.95, p = 0.373; CFI = 0.99; 
NFI = 0.97; RMSEA = 0.025 (90 confidence inter-
vals = 0.0–0.095). The constrained model was also very 
good (χ2 (df = 21) = 20.92, p = 0.464; CFI = 1; NFI = 0.94; 
RMSEA = 0.001 (90 confidence intervals = 0.0–0.074). 
The chi-square difference test, Δχ2 (df = 9), 7.81, p > 0.05 
was nonsignificant, so our interpretations focus on the full 
model. The inclusion of freely estimated nonsignificant 
paths did not change statistical significance, direction, or 
magnitude of effects, except for one path—that from disease 
activity to closeness to friends—where the path coefficient 
changed from − 0.24 to − 0.35, and moved from p < 0.01 
to p < 0.001.
Betas for significant paths from the full model are shown 
in Fig. 1. They show that current IBD disease activity influ-
enced how AYA felt about their friendships and how embar-
rassed they were about their condition; embarrassment then 
influenced reports of internalising problems. Abdominal 
pain, disease onset, and social self-efficacy directly predicted 
internalising problems: the more pain, the older they were 
Table 2  Participant numbers in cut-off groups for internalising prob-
lems (depressive symptoms, anxiety, and loneliness)
Number of AYA 
in sample
% Of sample
GAD-7
 Not anxious 64 49.2
 Mild anxiety 35 26.9
 Moderate  anxiety 18 13.8
 Severe anxiety 13 10.0
PHQ-8
 Not depressed 60 46.2
 Other depression 57 43.8
 Moderate/severe depression 13 10
Loneliness
 Lonely 14 10.8
 Not lonely 116 89.2
Table 3  Multiple regression 
with as predictors of depressive 
symptoms, anxiety, and 
loneliness
*p < .05, **p < .001
Internalising problems
Anxiety Depressive symptoms Loneliness
ΔR2 Β ΔR2 β ΔR2 β
Step 1 .074 .094* .023
 Gender .005 −.065 −.039
 Age .160 .211* .125
 Years with IBD .281 −.109 −.109
Step 2 .118* .109*** .028
 Current disease activity −.055 −.056 −.001
 Pain Level .281* .279* .089
Step 3 .273* .405*** .130
 Embarrassment of disorder .468** .374** .280*
 Social self−efficacy −.267* −.326** −.220*
 Friendship quality −.151 −.060
Total R2 .418* .453** .426
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when diagnosed with IBD, and the lower their social self-
efficacy, the higher their internalising problems.
Discussion
In the current study, we investigated how IBD influenced 
mental health and well-being among adolescents and young 
adults (AYA). Consistent with previous research, IBD dis-
ease activity was found to influence mental health reporting; 
extending that work, we also found that it did so indirectly by 
affecting how young people felt about their friendships and 
how embarrassed they were about their condition. Essen-
tially, having more symptoms meant AYA were more embar-
rassed and felt their condition affected their relationships 
with others. Given the unpredictable nature of the condi-
tion, patients reported being embarrassed about their symp-
toms and felt socially restricted because of them. Further, 
abdominal pain, later disease onset, and lower social self-
efficacy were found to directly predict poor mental health. 
Those findings provide empirical evidence that how AYA 
feel about their social life and how that is affected by the 
condition contributes to their mental health and well-being. 
Age at onset of the disease was also important, suggesting 
that certain age-related experiences may be risk factors for 
mental health among AYA with IBD.
Consistent with previous research, there was a significant 
relationship between mental ill-health and elevated rates of 
abdominal pain. Such findings suggest that the management 
of pain could reduce mental ill-health for those with IBD. 
However, there may be mechanisms at work that were not 
examined in the current study: given that pain is associ-
ated with chronic fatigue in many diseases among AYA [48, 
49], and fatigue is associated with depressive symptoms in 
patients [50, 51], the management of pain, because it is asso-
ciated with fatigue, could reduce mental ill-health for those 
with IBD. The examination of the role of fatigue in the pro-
spective relationship between pain and mental ill-health in 
AYA with IBD should be a focus of future work.
Onset of IBD was also associated with mental health: 
later onset was associated with poorer mental health. In 
another recent study [52] patients between 18 and 40 years 
Fig. 1  Final SEM model. *p < .01, **p < .001. The latent vari-
able ‘Internalising problems’ is made up of total scores for loneli-
ness (β = .64***), depressive symptoms (β = .94***), and anxi-
ety (β = .89***). The path estimates included here are from the full 
model that allowed the nonsignificant paths to be freely estimated. 
Their inclusion does not have a substantive impact on the statisti-
cal significance, direction, or magnitude of effects compared to the 
restricted model, where the nonsignificant paths were fixed to zero. 
The only change was in the magnitude and significance of the path 
from disease activity to closeness to friends, where the path coef-
ficient changed from −  .24 to −  .35 and moved from p < .01 to 
p < .001. Age and gender were not related to any other variables in the 
earlier multiple regression and so were not included in SEM analysis
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of age at the onset of Crohn’s disease or colitis were more at 
risk of developing anxiety and depressive symptoms com-
pared to patients over 40 years. Our results add to those find-
ings, but show that among young people ages 14–25 years, 
it is those with later onset of the disease who report poorer 
mental health. Together, findings suggest there may be a 
sensitive period in development where onset of IBD is most 
problematic, and that may not start in adolescence but in 
young adulthood. Thus, there is a need to explore the impact 
of age of onset of IBD more systematically in future studies 
to understand whether there are specific age groups who are 
more at risk and why. The mechanism linking age of onset to 
mental health should also be explored in future prospective 
studies: what is it about the experience of IBD symptoms at 
certain ages that make mental health challenges more likely?
Consistent with our expectations, we found that disease 
activity was associated with mental health, but it did so 
indirectly via embarrassment, affecting how AYA felt about 
their friendships. Given the social stigma that surrounds 
IBD symptoms [11, 27], it is unsurprising that feelings of 
embarrassment and worries about friendships are elevated 
during times of heightened disease activity. The unpredict-
able nature of symptoms and the frustrating treatment and 
management regimes make for embarrassing social experi-
ences and restricted social relationships. Our findings, then, 
suggest that addressing the social stigma that surrounds IBD 
and supporting AYA through real and perceived relation-
ships difficulties are important considerations for interven-
tion designs.
Implications of the findings
The findings suggest a clear need for screening of men-
tal health for AYA with IBD, and the use of standardised 
instruments with good sensitivity to monitor and improve 
individual outcomes over time. Understanding the role that 
social relationships and stigma have on the individual and at 
key points in the disease activity is important. One outcome 
of our findings could be the systematic screening of AYA 
with IBD, to create opportunities to consider appropriate 
preventive and supportive interventions for early signs of 
distress, rather than waiting to respond until a more severe 
psychological impairment emerges. Where screening is not 
possible, creating opportunities to discuss mental health 
challenges with each patient will be important, making dis-
cussion of mental health a natural part of the clinical con-
versation. Where regular screening is possible, there will be 
opportunities to monitor any changes in the mental health 
care needs of AYA patients over time, and for research to 
explore the impact of new disease-modifying therapies on 
mental health outcomes. Given the finding that embarrass-
ment mediates the relationship between IBD activity and 
mental health outcome and impacts perceived closeness to 
friends, we recommend that these be seen as potential foci 
in therapeutic work for youth with IBD and also in future 
research.
Limitations of the current study and future 
work
Given the increased risk of mental health problems among 
AYA with IBD, it is possible that those individuals in the 
sample who had an early diagnosis of IBD had also under-
gone treatment for mental health problems, particularly in 
centres where there is a holistic approach to health care. 
Thus, findings from the current study that later diagnosis 
among AYA is associated with poorer mental health may 
reflect the fact that treatment of mental health problems is 
already happening for those with earlier diagnosis. That 
said, we are not aware of any special mental health support 
available in those clinics we recruited from, suggesting that 
the mental health support came from elsewhere, most likely 
from their parents and friends. Future research will need to 
explore that possibility and look at individual context more 
explicitly.
Conclusion
In the current study, depressive symptoms, anxiety, and 
loneliness were common experiences for some adolescents 
and young adults (AYA) with IBD. The findings suggest 
that aspects of the condition are associated with mental 
health challenges in the current cohort, but that embarrass-
ment surrounding the condition and the perceived impact 
on friendships were also important. We conclude by argu-
ing that patients should have opportunities to discuss their 
mental health within the usual clinical dialogue, such that 
clinics help AYA with all challenges associated with living 
with IBD, including the impacts it has on social relationships 
and quality of life.
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